Application of Patient-Generated Health Data Among Older Adults With Cancer: Scoping Review
The advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated health data (PGHD). In particular, PGHD may be promising for older adults with cancer who have increased survival rates and experience a variety of symptoms...
Saved in:
Published in | Journal of medical Internet research Vol. 27; no. 5; p. e57379 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Canada
Journal of Medical Internet Research
04.02.2025
Gunther Eysenbach MD MPH, Associate Professor JMIR Publications |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated health data (PGHD). In particular, PGHD may be promising for older adults with cancer who have increased survival rates and experience a variety of symptoms.
This scoping review aimed to identify the characteristics of research on PGHD as applied to older adults with cancer and to assess the current use of PGHD.
Guided by Arksey and O'Malley as well as the JBI (Joanna Briggs Institute) methodology for scoping reviews, 6 electronic databases were searched: PubMed, Embase, CINAHL, Cochrane Library, Scopus, and Web of Science. In addition, the reference lists of the selected studies were screened to identify gray literature. The researchers independently screened the literature according to the predefined eligibility criteria. Data from the selected studies were extracted, capturing study, participant, and PGHD characteristics.
Of the 1090 identified studies, 88 were selected. The publication trend gradually increased, with a majority of studies published since 2017 (69/88, 78%). Almost half of the studies were conducted in North America (38/88, 43%), followed by Europe (30/88, 34%). The most common setting in which the studies were conducted was the participant's home (69/88, 78%). The treatment status varied; the median sample size was 50 (IQR 33.8-84.0). The devices that were used to measure the PGHD were classified as research-grade wearable devices (57/113, 50.4%), consumer-grade wearable devices (28/113, 24.8%), or smartphones or tablet PCs for mobile apps (23/113, 20.4%). More than half of the studies measured physical activity (69/123, 56.1%), followed by patient-reported outcomes (23/123, 18.7%), vital signs (13/123, 10.6%), and sleep (12/123, 9.8%). The PGHD were mainly collected passively (63/88, 72%), and active collection methods were used from 2015 onward (20/88, 23%). In this review, the stages of PGHD use were classified as follows: (1) identification, monitoring, review, and analysis (88/88, 100%); (2) feedback and reporting (32/88, 39%); (3) motivation (30/88, 34%); and (4) education and coaching (19/88, 22%).
This scoping review provides a comprehensive summary of the overall characteristics and use stages of PGHD in older adults with various types and stages of cancer. Future research should emphasize the use of PGHD, which interacts with patients to provide patient-centered care through patient engagement. By enhancing symptom monitoring, enabling timely interventions, and promoting patient involvement, PGHD have the potential to improve the well-being of older adults with cancer, contributing to better health management and quality of life. Therefore, our findings may provide valuable insights into PGHD that health care providers and researchers can use for geriatric cancer care.
Open Science Framework Registry OSF.IO/FZRD5; https://doi.org/10.17605/OSF.IO/FZRD5. |
---|---|
AbstractList | Background:The advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated health data (PGHD). In particular, PGHD may be promising for older adults with cancer who have increased survival rates and experience a variety of symptoms.Objective:This scoping review aimed to identify the characteristics of research on PGHD as applied to older adults with cancer and to assess the current use of PGHD.Methods:Guided by Arksey and O’Malley as well as the JBI (Joanna Briggs Institute) methodology for scoping reviews, 6 electronic databases were searched: PubMed, Embase, CINAHL, Cochrane Library, Scopus, and Web of Science. In addition, the reference lists of the selected studies were screened to identify gray literature. The researchers independently screened the literature according to the predefined eligibility criteria. Data from the selected studies were extracted, capturing study, participant, and PGHD characteristics.Results:Of the 1090 identified studies, 88 were selected. The publication trend gradually increased, with a majority of studies published since 2017 (69/88, 78%). Almost half of the studies were conducted in North America (38/88, 43%), followed by Europe (30/88, 34%). The most common setting in which the studies were conducted was the participant’s home (69/88, 78%). The treatment status varied; the median sample size was 50 (IQR 33.8-84.0). The devices that were used to measure the PGHD were classified as research-grade wearable devices (57/113, 50.4%), consumer-grade wearable devices (28/113, 24.8%), or smartphones or tablet PCs for mobile apps (23/113, 20.4%). More than half of the studies measured physical activity (69/123, 56.1%), followed by patient-reported outcomes (23/123, 18.7%), vital signs (13/123, 10.6%), and sleep (12/123, 9.8%). The PGHD were mainly collected passively (63/88, 72%), and active collection methods were used from 2015 onward (20/88, 23%). In this review, the stages of PGHD use were classified as follows: (1) identification, monitoring, review, and analysis (88/88, 100%); (2) feedback and reporting (32/88, 39%); (3) motivation (30/88, 34%); and (4) education and coaching (19/88, 22%).Conclusions:This scoping review provides a comprehensive summary of the overall characteristics and use stages of PGHD in older adults with various types and stages of cancer. Future research should emphasize the use of PGHD, which interacts with patients to provide patient-centered care through patient engagement. By enhancing symptom monitoring, enabling timely interventions, and promoting patient involvement, PGHD have the potential to improve the well-being of older adults with cancer, contributing to better health management and quality of life. Therefore, our findings may provide valuable insights into PGHD that health care providers and researchers can use for geriatric cancer care.Trial Registration:Open Science Framework Registry OSF.IO/FZRD5; https://doi.org/10.17605/OSF.IO/FZRD5 The advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated health data (PGHD). In particular, PGHD may be promising for older adults with cancer who have increased survival rates and experience a variety of symptoms. This scoping review aimed to identify the characteristics of research on PGHD as applied to older adults with cancer and to assess the current use of PGHD. Guided by Arksey and O'Malley as well as the JBI (Joanna Briggs Institute) methodology for scoping reviews, 6 electronic databases were searched: PubMed, Embase, CINAHL, Cochrane Library, Scopus, and Web of Science. In addition, the reference lists of the selected studies were screened to identify gray literature. The researchers independently screened the literature according to the predefined eligibility criteria. Data from the selected studies were extracted, capturing study, participant, and PGHD characteristics. Of the 1090 identified studies, 88 were selected. The publication trend gradually increased, with a majority of studies published since 2017 (69/88, 78%). Almost half of the studies were conducted in North America (38/88, 43%), followed by Europe (30/88, 34%). The most common setting in which the studies were conducted was the participant's home (69/88, 78%). The treatment status varied; the median sample size was 50 (IQR 33.8-84.0). The devices that were used to measure the PGHD were classified as research-grade wearable devices (57/113, 50.4%), consumer-grade wearable devices (28/113, 24.8%), or smartphones or tablet PCs for mobile apps (23/113, 20.4%). More than half of the studies measured physical activity (69/123, 56.1%), followed by patient-reported outcomes (23/123, 18.7%), vital signs (13/123, 10.6%), and sleep (12/123, 9.8%). The PGHD were mainly collected passively (63/88, 72%), and active collection methods were used from 2015 onward (20/88, 23%). In this review, the stages of PGHD use were classified as follows: (1) identification, monitoring, review, and analysis (88/88, 100%); (2) feedback and reporting (32/88, 39%); (3) motivation (30/88, 34%); and (4) education and coaching (19/88, 22%). This scoping review provides a comprehensive summary of the overall characteristics and use stages of PGHD in older adults with various types and stages of cancer. Future research should emphasize the use of PGHD, which interacts with patients to provide patient-centered care through patient engagement. By enhancing symptom monitoring, enabling timely interventions, and promoting patient involvement, PGHD have the potential to improve the well-being of older adults with cancer, contributing to better health management and quality of life. Therefore, our findings may provide valuable insights into PGHD that health care providers and researchers can use for geriatric cancer care. Open Science Framework Registry OSF.IO/FZRD5; https://doi.org/10.17605/OSF.IO/FZRD5. The advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated health data (PGHD). In particular, PGHD may be promising for older adults with cancer who have increased survival rates and experience a variety of symptoms.BACKGROUNDThe advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated health data (PGHD). In particular, PGHD may be promising for older adults with cancer who have increased survival rates and experience a variety of symptoms.This scoping review aimed to identify the characteristics of research on PGHD as applied to older adults with cancer and to assess the current use of PGHD.OBJECTIVEThis scoping review aimed to identify the characteristics of research on PGHD as applied to older adults with cancer and to assess the current use of PGHD.Guided by Arksey and O'Malley as well as the JBI (Joanna Briggs Institute) methodology for scoping reviews, 6 electronic databases were searched: PubMed, Embase, CINAHL, Cochrane Library, Scopus, and Web of Science. In addition, the reference lists of the selected studies were screened to identify gray literature. The researchers independently screened the literature according to the predefined eligibility criteria. Data from the selected studies were extracted, capturing study, participant, and PGHD characteristics.METHODSGuided by Arksey and O'Malley as well as the JBI (Joanna Briggs Institute) methodology for scoping reviews, 6 electronic databases were searched: PubMed, Embase, CINAHL, Cochrane Library, Scopus, and Web of Science. In addition, the reference lists of the selected studies were screened to identify gray literature. The researchers independently screened the literature according to the predefined eligibility criteria. Data from the selected studies were extracted, capturing study, participant, and PGHD characteristics.Of the 1090 identified studies, 88 were selected. The publication trend gradually increased, with a majority of studies published since 2017 (69/88, 78%). Almost half of the studies were conducted in North America (38/88, 43%), followed by Europe (30/88, 34%). The most common setting in which the studies were conducted was the participant's home (69/88, 78%). The treatment status varied; the median sample size was 50 (IQR 33.8-84.0). The devices that were used to measure the PGHD were classified as research-grade wearable devices (57/113, 50.4%), consumer-grade wearable devices (28/113, 24.8%), or smartphones or tablet PCs for mobile apps (23/113, 20.4%). More than half of the studies measured physical activity (69/123, 56.1%), followed by patient-reported outcomes (23/123, 18.7%), vital signs (13/123, 10.6%), and sleep (12/123, 9.8%). The PGHD were mainly collected passively (63/88, 72%), and active collection methods were used from 2015 onward (20/88, 23%). In this review, the stages of PGHD use were classified as follows: (1) identification, monitoring, review, and analysis (88/88, 100%); (2) feedback and reporting (32/88, 39%); (3) motivation (30/88, 34%); and (4) education and coaching (19/88, 22%).RESULTSOf the 1090 identified studies, 88 were selected. The publication trend gradually increased, with a majority of studies published since 2017 (69/88, 78%). Almost half of the studies were conducted in North America (38/88, 43%), followed by Europe (30/88, 34%). The most common setting in which the studies were conducted was the participant's home (69/88, 78%). The treatment status varied; the median sample size was 50 (IQR 33.8-84.0). The devices that were used to measure the PGHD were classified as research-grade wearable devices (57/113, 50.4%), consumer-grade wearable devices (28/113, 24.8%), or smartphones or tablet PCs for mobile apps (23/113, 20.4%). More than half of the studies measured physical activity (69/123, 56.1%), followed by patient-reported outcomes (23/123, 18.7%), vital signs (13/123, 10.6%), and sleep (12/123, 9.8%). The PGHD were mainly collected passively (63/88, 72%), and active collection methods were used from 2015 onward (20/88, 23%). In this review, the stages of PGHD use were classified as follows: (1) identification, monitoring, review, and analysis (88/88, 100%); (2) feedback and reporting (32/88, 39%); (3) motivation (30/88, 34%); and (4) education and coaching (19/88, 22%).This scoping review provides a comprehensive summary of the overall characteristics and use stages of PGHD in older adults with various types and stages of cancer. Future research should emphasize the use of PGHD, which interacts with patients to provide patient-centered care through patient engagement. By enhancing symptom monitoring, enabling timely interventions, and promoting patient involvement, PGHD have the potential to improve the well-being of older adults with cancer, contributing to better health management and quality of life. Therefore, our findings may provide valuable insights into PGHD that health care providers and researchers can use for geriatric cancer care.CONCLUSIONSThis scoping review provides a comprehensive summary of the overall characteristics and use stages of PGHD in older adults with various types and stages of cancer. Future research should emphasize the use of PGHD, which interacts with patients to provide patient-centered care through patient engagement. By enhancing symptom monitoring, enabling timely interventions, and promoting patient involvement, PGHD have the potential to improve the well-being of older adults with cancer, contributing to better health management and quality of life. Therefore, our findings may provide valuable insights into PGHD that health care providers and researchers can use for geriatric cancer care.Open Science Framework Registry OSF.IO/FZRD5; https://doi.org/10.17605/OSF.IO/FZRD5.TRIAL REGISTRATIONOpen Science Framework Registry OSF.IO/FZRD5; https://doi.org/10.17605/OSF.IO/FZRD5. Background The advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated health data (PGHD). In particular, PGHD may be promising for older adults with cancer who have increased survival rates and experience a variety of symptoms. Objective This scoping review aimed to identify the characteristics of research on PGHD as applied to older adults with cancer and to assess the current use of PGHD. Methods Guided by Arksey and O’Malley as well as the JBI (Joanna Briggs Institute) methodology for scoping reviews, 6 electronic databases were searched: PubMed, Embase, CINAHL, Cochrane Library, Scopus, and Web of Science. In addition, the reference lists of the selected studies were screened to identify gray literature. The researchers independently screened the literature according to the predefined eligibility criteria. Data from the selected studies were extracted, capturing study, participant, and PGHD characteristics. Results Of the 1090 identified studies, 88 were selected. The publication trend gradually increased, with a majority of studies published since 2017 (69/88, 78%). Almost half of the studies were conducted in North America (38/88, 43%), followed by Europe (30/88, 34%). The most common setting in which the studies were conducted was the participant’s home (69/88, 78%). The treatment status varied; the median sample size was 50 (IQR 33.8-84.0). The devices that were used to measure the PGHD were classified as research-grade wearable devices (57/113, 50.4%), consumer-grade wearable devices (28/113, 24.8%), or smartphones or tablet PCs for mobile apps (23/113, 20.4%). More than half of the studies measured physical activity (69/123, 56.1%), followed by patient-reported outcomes (23/123, 18.7%), vital signs (13/123, 10.6%), and sleep (12/123, 9.8%). The PGHD were mainly collected passively (63/88, 72%), and active collection methods were used from 2015 onward (20/88, 23%). In this review, the stages of PGHD use were classified as follows: (1) identification, monitoring, review, and analysis (88/88, 100%); (2) feedback and reporting (32/88, 39%); (3) motivation (30/88, 34%); and (4) education and coaching (19/88, 22%). Conclusions This scoping review provides a comprehensive summary of the overall characteristics and use stages of PGHD in older adults with various types and stages of cancer. Future research should emphasize the use of PGHD, which interacts with patients to provide patient-centered care through patient engagement. By enhancing symptom monitoring, enabling timely interventions, and promoting patient involvement, PGHD have the potential to improve the well-being of older adults with cancer, contributing to better health management and quality of life. Therefore, our findings may provide valuable insights into PGHD that health care providers and researchers can use for geriatric cancer care. Trial Registration Open Science Framework Registry OSF.IO/FZRD5; BackgroundThe advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated health data (PGHD). In particular, PGHD may be promising for older adults with cancer who have increased survival rates and experience a variety of symptoms. ObjectiveThis scoping review aimed to identify the characteristics of research on PGHD as applied to older adults with cancer and to assess the current use of PGHD. MethodsGuided by Arksey and O’Malley as well as the JBI (Joanna Briggs Institute) methodology for scoping reviews, 6 electronic databases were searched: PubMed, Embase, CINAHL, Cochrane Library, Scopus, and Web of Science. In addition, the reference lists of the selected studies were screened to identify gray literature. The researchers independently screened the literature according to the predefined eligibility criteria. Data from the selected studies were extracted, capturing study, participant, and PGHD characteristics. ResultsOf the 1090 identified studies, 88 were selected. The publication trend gradually increased, with a majority of studies published since 2017 (69/88, 78%). Almost half of the studies were conducted in North America (38/88, 43%), followed by Europe (30/88, 34%). The most common setting in which the studies were conducted was the participant’s home (69/88, 78%). The treatment status varied; the median sample size was 50 (IQR 33.8-84.0). The devices that were used to measure the PGHD were classified as research-grade wearable devices (57/113, 50.4%), consumer-grade wearable devices (28/113, 24.8%), or smartphones or tablet PCs for mobile apps (23/113, 20.4%). More than half of the studies measured physical activity (69/123, 56.1%), followed by patient-reported outcomes (23/123, 18.7%), vital signs (13/123, 10.6%), and sleep (12/123, 9.8%). The PGHD were mainly collected passively (63/88, 72%), and active collection methods were used from 2015 onward (20/88, 23%). In this review, the stages of PGHD use were classified as follows: (1) identification, monitoring, review, and analysis (88/88, 100%); (2) feedback and reporting (32/88, 39%); (3) motivation (30/88, 34%); and (4) education and coaching (19/88, 22%). ConclusionsThis scoping review provides a comprehensive summary of the overall characteristics and use stages of PGHD in older adults with various types and stages of cancer. Future research should emphasize the use of PGHD, which interacts with patients to provide patient-centered care through patient engagement. By enhancing symptom monitoring, enabling timely interventions, and promoting patient involvement, PGHD have the potential to improve the well-being of older adults with cancer, contributing to better health management and quality of life. Therefore, our findings may provide valuable insights into PGHD that health care providers and researchers can use for geriatric cancer care. Trial RegistrationOpen Science Framework Registry OSF.IO/FZRD5; https://doi.org/10.17605/OSF.IO/FZRD5 The advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated health data (PGHD). In particular, PGHD may be promising for older adults with cancer who have increased survival rates and experience a variety of symptoms. This scoping review aimed to identify the characteristics of research on PGHD as applied to older adults with cancer and to assess the current use of PGHD. Guided by Arksey and O’Malley as well as the JBI (Joanna Briggs Institute) methodology for scoping reviews, 6 electronic databases were searched: PubMed, Embase, CINAHL, Cochrane Library, Scopus, and Web of Science. In addition, the reference lists of the selected studies were screened to identify gray literature. The researchers independently screened the literature according to the predefined eligibility criteria. Data from the selected studies were extracted, capturing study, participant, and PGHD characteristics. Of the 1090 identified studies, 88 were selected. The publication trend gradually increased, with a majority of studies published since 2017 (69/88, 78%). Almost half of the studies were conducted in North America (38/88, 43%), followed by Europe (30/88, 34%). The most common setting in which the studies were conducted was the participant’s home (69/88, 78%). The treatment status varied; the median sample size was 50 (IQR 33.8-84.0). The devices that were used to measure the PGHD were classified as research-grade wearable devices (57/113, 50.4%), consumer-grade wearable devices (28/113, 24.8%), or smartphones or tablet PCs for mobile apps (23/113, 20.4%). More than half of the studies measured physical activity (69/123, 56.1%), followed by patient-reported outcomes (23/123, 18.7%), vital signs (13/123, 10.6%), and sleep (12/123, 9.8%). The PGHD were mainly collected passively (63/88, 72%), and active collection methods were used from 2015 onward (20/88, 23%). In this review, the stages of PGHD use were classified as follows: (1) identification, monitoring, review, and analysis (88/88, 100%); (2) feedback and reporting (32/88, 39%); (3) motivation (30/88, 34%); and (4) education and coaching (19/88, 22%). This scoping review provides a comprehensive summary of the overall characteristics and use stages of PGHD in older adults with various types and stages of cancer. Future research should emphasize the use of PGHD, which interacts with patients to provide patient-centered care through patient engagement. By enhancing symptom monitoring, enabling timely interventions, and promoting patient involvement, PGHD have the potential to improve the well-being of older adults with cancer, contributing to better health management and quality of life. Therefore, our findings may provide valuable insights into PGHD that health care providers and researchers can use for geriatric cancer care. |
Audience | Academic |
Author | Kim, Yesol Kim, Yeonju Choi, Mona Kim, Geonah Cho, Hyeonmi |
AuthorAffiliation | 4 Mo-Im Kim Nursing Research Institute College of Nursing Yonsei University Seoul Republic of Korea 1 College of Nursing and Brain Korea 21 FOUR Project Yonsei University Seoul Republic of Korea 5 Research Institute of AI and Nursing Science College of Nursing Gachon University Incheon Republic of Korea 6 Yonsei Evidence Based Nursing Centre, A JBI Affiliated Group Seoul Republic of Korea 3 Severance Hospital Yonsei University Health System Seoul Republic of Korea 2 College of Nursing Gyeongsang National University Jinju Republic of Korea |
AuthorAffiliation_xml | – name: 6 Yonsei Evidence Based Nursing Centre, A JBI Affiliated Group Seoul Republic of Korea – name: 3 Severance Hospital Yonsei University Health System Seoul Republic of Korea – name: 1 College of Nursing and Brain Korea 21 FOUR Project Yonsei University Seoul Republic of Korea – name: 2 College of Nursing Gyeongsang National University Jinju Republic of Korea – name: 5 Research Institute of AI and Nursing Science College of Nursing Gachon University Incheon Republic of Korea – name: 4 Mo-Im Kim Nursing Research Institute College of Nursing Yonsei University Seoul Republic of Korea |
Author_xml | – sequence: 1 givenname: Yesol orcidid: 0000-0002-3540-1723 surname: Kim fullname: Kim, Yesol – sequence: 2 givenname: Geonah orcidid: 0009-0008-5373-133X surname: Kim fullname: Kim, Geonah – sequence: 3 givenname: Hyeonmi orcidid: 0000-0001-7296-2581 surname: Cho fullname: Cho, Hyeonmi – sequence: 4 givenname: Yeonju orcidid: 0009-0001-6797-6716 surname: Kim fullname: Kim, Yeonju – sequence: 5 givenname: Mona orcidid: 0000-0003-4694-0359 surname: Choi fullname: Choi, Mona |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39903506$$D View this record in MEDLINE/PubMed |
BookMark | eNptkttu1DAQhiNURA_0FVAkhMRNig9xbHODVgu0lSoVcRAXXFgTZ7z1KrG3TlLE2-N2S-ki5AuPZj7_4xn9h8VeiAGL4piSE0Z180ZILvWT4oDWXFVKSbr3KN4vDsdxTQgjtabPin2uNeGCNAfFj8Vm03sLk4-hjK78lCMMU3WKARNM2JVnCP10Vb6HCcrFEMOqvOw7TOWim_tpLL_7XFxCsJjell9s3PhMfMYbjz-fF08d9CMe399HxbePH74uz6qLy9Pz5eKisrXSU1VbRGhZrSQ2xCnrrAIpaFszELJjUgAQrRwXmgmrrOqscFwB72rnXGsZPyrOt7pdhLXZJD9A-mUieHOXiGllIE3e9mia2gqrGyWolDV3rQLVuJyTUqDjQLLWu63WZm4H7GzeRYJ-R3S3EvyVWcUbQ6nijdA0K7y-V0jxesZxMoMfLfY9BIzzaDht8uqpIDqjL_9B13FOIe_KcMYYz_9k8i-1gjyBDy7mxvZW1CwUa6hiNRGZOvkPlU-Hg7fZK87n_M6DF48nfRjxjzcy8GoL2BTHMaF7QCgxt54zd57jvwE3U8UM |
Cites_doi | 10.2196/mhealth.6829 10.2196/jmir.7838 10.3322/caac.21731 10.1007/s00520-018-4493-6 10.1016/j.lungcan.2013.11.014 10.1177/1534735416684016 10.11124/JBIES-20-00167 10.1097/SPC.0000000000000439 10.2196/humanfactors.5919 10.1249/MSS.0000000000000241 10.1111/ecc.13497 10.1111/j.1365-2354.2010.01205.x 10.1186/s12955-020-01480-3 10.1371/journal.pone.0246101 10.2196/35694 10.1177/1932296817750401 10.5993/AJHB.44.1.10 10.2196/18819 10.1186/s12966-018-0734-9 10.1016/j.cppeds.2021.101103 10.1007/s00520-014-2177-4 10.1007/s10552-009-9460-6 10.1002/cncr.29385 10.2196/cancer.7599 10.1001/jamanetworkopen.2021.22998 10.3390/cancers13235925 10.1007/s00520-019-04998-5 10.3390/cancers12071938 10.1080/1364557032000119616 10.1371/journal.pone.0240967 10.3109/07420528.2013.864301 10.1002/cncr.31745 10.1007/s11764-012-0239-5 10.1097/NCC.0000000000000647 10.1177/1534735419894061 10.1245/s10434-020-08705-1 10.1016/j.eururo.2018.12.040 10.1002/cncr.28951 10.1249/MSS.0000000000000727 10.2196/14537 10.1016/j.semradonc.2019.05.008 10.1007/s00520-017-3721-9 10.2196/19180 10.2196/34384 10.1016/j.jpainsymman.2006.03.014 10.1002/cncr.31024 10.2196/20738 10.1200/EDBK_390678 10.1111/ijn.13019 10.2196/27349 10.1016/j.jgo.2022.06.004 10.1080/0284186X.2021.1896032 10.1111/jgs.17369 10.1007/s00520-019-05230-0 10.1080/07420528.2017.1293678 10.1016/j.ejon.2015.02.013 10.7748/phc.2017.e1225 10.1002/jso.26413 10.2196/17855 10.1007/s11764-022-01260-6 10.2196/29788 10.1016/j.clon.2021.04.008 10.1002/cam4.4382 10.1016/j.jgo.2019.01.010 10.2196/25791 10.14423/SMJ.0000000000000956 10.2196/mhealth.5426 10.1111/ijn.12658 10.1111/jgs.14589 10.1007/s00066-019-01548-0 10.1016/j.ejso.2019.04.013 10.1123/jmpb.2021-0046 10.1158/1078-0432.CCR-07-1147 10.2196/27975 10.2196/36284 10.1016/j.outlook.2019.04.005 10.3109/13685538.2011.582528 10.1200/JOP.2015.003715 10.4258/hir.2021.27.4.267 10.2307/249008 10.1097/NCC.0000000000000128 10.1038/s41430-019-0418-9 10.1016/j.pmedr.2016.06.022 10.1007/s10552-016-0787-5 10.1080/07420528.2017.1391278 10.3390/cancers14112742 10.1177/1534735414542484 10.1245/s10434-021-09707-3 10.1016/j.ijrobp.2017.02.002 10.2196/47380 10.1002/jso.25789 10.2196/29027 10.7326/M18-0850 10.3322/caac.21608 10.1016/S1470-2045(18)30348-6 10.1186/s12885-022-09629-7 10.1016/j.jgo.2017.09.008 10.1016/j.clml.2020.06.024 10.21037/jtd.2020.01.23 10.1136/bmjopen-2020-046393 10.2196/13320 10.1177/1049909113510963 10.1007/s12529-016-9575-6 10.1016/j.ejso.2020.06.012 10.1017/S1478951517000815 10.1001/jamasurg.2019.4702 10.1016/j.jpainsymman.2019.08.016 10.1007/s00520-009-0776-2 10.1186/s12966-018-0686-0 10.1097/CIN.0000000000001109 10.1016/j.lungcan.2018.03.010 10.1080/0284186X.2019.1633473 10.1016/j.urolonc.2020.11.035 10.1177/1049909116649948 10.1186/s12885-018-5189-5 10.1136/bmjopen-2018-025114 10.1097/JU.0000000000000050 10.1186/s41687-020-00255-0 10.1186/s12885-021-08084-0 10.1017/S1478951518001074 10.1139/H07-074 10.1007/978-3-031-27173-1_15 10.2196/19238 10.1007/s00520-017-3625-8 10.1007/s11764-016-0553-4 10.1007/s11764-013-0293-7 10.1016/j.eururo.2013.09.041 10.1093/jamia/ocv184 10.1016/S1470-2045(16)30573-3 |
ContentType | Journal Article |
Copyright | Yesol Kim, Geonah Kim, Hyeonmi Cho, Yeonju Kim, Mona Choi. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 04.02.2025. COPYRIGHT 2025 Journal of Medical Internet Research 2025. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Yesol Kim, Geonah Kim, Hyeonmi Cho, Yeonju Kim, Mona Choi. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 04.02.2025. 2025 |
Copyright_xml | – notice: Yesol Kim, Geonah Kim, Hyeonmi Cho, Yeonju Kim, Mona Choi. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 04.02.2025. – notice: COPYRIGHT 2025 Journal of Medical Internet Research – notice: 2025. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Yesol Kim, Geonah Kim, Hyeonmi Cho, Yeonju Kim, Mona Choi. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 04.02.2025. 2025 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QJ 7RV 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA ALSLI AZQEC BENPR CCPQU CNYFK DWQXO E3H F2A FYUFA GHDGH K9. KB0 M0S M1O NAPCQ PHGZM PHGZT PIMPY PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PRQQA 7X8 5PM DOA |
DOI | 10.2196/57379 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Applied Social Sciences Index & Abstracts (ASSIA) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland Social Science Premium Collection ProQuest Central Essentials ProQuest Central ProQuest One Library & Information Science Collection ProQuest Central Korea Library & Information Sciences Abstracts (LISA) Library & Information Science Abstracts (LISA) Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Library Science Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Social Sciences MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) Library and Information Science Abstracts (LISA) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Applied Social Sciences Index and Abstracts (ASSIA) ProQuest Central China ProQuest Central ProQuest Library Science Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Library & Information Science Collection ProQuest Central (New) Social Science Premium Collection ProQuest One Social Sciences ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Library & Information Science |
EISSN | 1438-8871 |
ExternalDocumentID | oai_doaj_org_article_64c5c968517743fb8a86f4c5775ef3a0 PMC11836591 A826182405 39903506 10_2196_57379 |
Genre | Journal Article Scoping Review |
GeographicLocations | South Korea United States--US |
GeographicLocations_xml | – name: South Korea – name: United States--US |
GroupedDBID | --- .4I .DC 29L 2WC 36B 53G 5GY 5VS 77K 7RV 7X7 8FI 8FJ AAFWJ AAKPC AAWTL AAYXX ABDBF ABIVO ABUWG ACGFO ADBBV AEGXH AENEX AFKRA AFPKN AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS ALSLI AOIJS BAWUL BCNDV BENPR CCPQU CITATION CNYFK CS3 DIK DU5 DWQXO E3Z EAP EBD EBS EJD ELW EMB EMOBN ESX F5P FRP FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO ICO IEA IHR INH ISN ITC KQ8 M1O M48 NAPCQ OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ RNS RPM SJN SV3 TR2 UKHRP XSB ACUHS CGR CUY CVF ECM EIF NPM PPXIY PRQQA PMFND 3V. 7QJ 7XB 8FK AZQEC E3H F2A K9. PKEHL PQEST PQUKI PRINS PUEGO 7X8 5PM |
ID | FETCH-LOGICAL-c489t-4ceeab2487e60f8cfc8a751b42a57d275aa098f35925c8c8dc5f38a3d4fffbc23 |
IEDL.DBID | 7X7 |
ISSN | 1438-8871 1439-4456 |
IngestDate | Wed Aug 27 01:29:04 EDT 2025 Thu Aug 21 18:28:41 EDT 2025 Fri Jul 11 07:02:54 EDT 2025 Sat Aug 23 13:49:53 EDT 2025 Tue Jun 17 22:00:07 EDT 2025 Tue Jun 10 20:57:47 EDT 2025 Mon Jul 21 06:01:36 EDT 2025 Tue Jul 01 02:06:21 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | patient-reported outcomes wearable devices patient-centered care older adults cancer patient-generated health data scoping review |
Language | English |
License | Yesol Kim, Geonah Kim, Hyeonmi Cho, Yeonju Kim, Mona Choi. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 04.02.2025. This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research (ISSN 1438-8871), is properly cited. The complete bibliographic information, a link to the original publication on https://www.jmir.org/, as well as this copyright and license information must be included. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c489t-4ceeab2487e60f8cfc8a751b42a57d275aa098f35925c8c8dc5f38a3d4fffbc23 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
ORCID | 0009-0008-5373-133X 0009-0001-6797-6716 0000-0003-4694-0359 0000-0001-7296-2581 0000-0002-3540-1723 |
OpenAccessLink | https://www.proquest.com/docview/3222368527?pq-origsite=%requestingapplication% |
PMID | 39903506 |
PQID | 3222368527 |
PQPubID | 2033121 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_64c5c968517743fb8a86f4c5775ef3a0 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11836591 proquest_miscellaneous_3163501509 proquest_journals_3222368527 gale_infotracmisc_A826182405 gale_infotracacademiconefile_A826182405 pubmed_primary_39903506 crossref_primary_10_2196_57379 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20250204 |
PublicationDateYYYYMMDD | 2025-02-04 |
PublicationDate_xml | – month: 2 year: 2025 text: 20250204 day: 4 |
PublicationDecade | 2020 |
PublicationPlace | Canada |
PublicationPlace_xml | – name: Canada – name: Toronto – name: Toronto, Canada |
PublicationTitle | Journal of medical Internet research |
PublicationTitleAlternate | J Med Internet Res |
PublicationYear | 2025 |
Publisher | Journal of Medical Internet Research Gunther Eysenbach MD MPH, Associate Professor JMIR Publications |
Publisher_xml | – name: Journal of Medical Internet Research – name: Gunther Eysenbach MD MPH, Associate Professor – name: JMIR Publications |
References | ref57 ref56 ref59 ref58 ref53 ref52 ref55 ref54 ref51 ref50 ref46 ref45 ref48 ref47 ref42 ref41 Morgan, R (ref120) 2023 ref44 ref43 ref49 ref8 ref7 ref9 ref4 ref3 ref6 ref5 ref100 ref101 ref40 ref35 ref34 ref37 ref36 ref31 ref30 ref33 ref32 ref39 ref38 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref28 ref27 ref29 ref13 ref12 ref15 ref128 ref14 ref129 ref97 ref126 ref96 ref127 ref11 ref99 ref124 ref10 ref98 ref125 ref17 ref16 ref19 ref18 ref93 ref92 ref95 ref94 ref130 ref91 ref90 ref89 ref86 ref85 ref88 ref87 ref82 ref81 ref84 ref83 ref80 ref79 ref108 ref78 ref109 ref106 ref107 ref75 ref104 ref74 ref105 ref77 ref102 ref76 ref103 ref2 ref1 ref71 ref111 ref70 ref112 ref73 ref72 ref110 ref68 ref119 ref67 ref117 ref69 ref118 ref64 ref115 ref63 ref116 ref66 ref113 ref65 ref114 ref60 ref122 ref123 ref62 ref61 ref121 |
References_xml | – ident: ref42 doi: 10.2196/mhealth.6829 – ident: ref38 doi: 10.2196/jmir.7838 – ident: ref1 doi: 10.3322/caac.21731 – ident: ref65 doi: 10.1007/s00520-018-4493-6 – ident: ref27 doi: 10.1016/j.lungcan.2013.11.014 – ident: ref46 doi: 10.1177/1534735416684016 – ident: ref14 doi: 10.11124/JBIES-20-00167 – ident: ref5 doi: 10.1097/SPC.0000000000000439 – ident: ref106 doi: 10.2196/humanfactors.5919 – ident: ref116 doi: 10.1249/MSS.0000000000000241 – ident: ref96 doi: 10.1111/ecc.13497 – ident: ref9 – ident: ref22 doi: 10.1111/j.1365-2354.2010.01205.x – ident: ref83 doi: 10.1186/s12955-020-01480-3 – ident: ref95 doi: 10.1371/journal.pone.0246101 – ident: ref101 doi: 10.2196/35694 – ident: ref112 doi: 10.1177/1932296817750401 – ident: ref82 doi: 10.5993/AJHB.44.1.10 – ident: ref87 doi: 10.2196/18819 – ident: ref50 doi: 10.1186/s12966-018-0734-9 – ident: ref107 doi: 10.1016/j.cppeds.2021.101103 – ident: ref24 doi: 10.1007/s00520-014-2177-4 – ident: ref19 doi: 10.1007/s10552-009-9460-6 – ident: ref31 doi: 10.1002/cncr.29385 – ident: ref40 doi: 10.2196/cancer.7599 – ident: ref92 doi: 10.1001/jamanetworkopen.2021.22998 – ident: ref88 doi: 10.3390/cancers13235925 – ident: ref73 doi: 10.1007/s00520-019-04998-5 – ident: ref78 doi: 10.3390/cancers12071938 – ident: ref13 doi: 10.1080/1364557032000119616 – ident: ref72 doi: 10.1371/journal.pone.0240967 – ident: ref28 doi: 10.3109/07420528.2013.864301 – ident: ref55 doi: 10.1002/cncr.31745 – ident: ref6 doi: 10.1007/s11764-012-0239-5 – ident: ref76 doi: 10.1097/NCC.0000000000000647 – ident: ref64 doi: 10.1177/1534735419894061 – ident: ref90 doi: 10.1245/s10434-020-08705-1 – ident: ref60 doi: 10.1016/j.eururo.2018.12.040 – ident: ref108 doi: 10.1002/cncr.28951 – ident: ref113 doi: 10.1249/MSS.0000000000000727 – ident: ref128 doi: 10.2196/14537 – ident: ref105 doi: 10.1016/j.semradonc.2019.05.008 – ident: ref39 doi: 10.1007/s00520-017-3721-9 – ident: ref79 doi: 10.2196/19180 – ident: ref111 doi: 10.2196/34384 – ident: ref17 doi: 10.1016/j.jpainsymman.2006.03.014 – ident: ref51 doi: 10.1002/cncr.31024 – ident: ref110 doi: 10.2196/20738 – ident: ref119 doi: 10.1200/EDBK_390678 – ident: ref102 doi: 10.1111/ijn.13019 – ident: ref104 doi: 10.2196/27349 – ident: ref125 doi: 10.1016/j.jgo.2022.06.004 – ident: ref93 doi: 10.1080/0284186X.2021.1896032 – ident: ref4 doi: 10.1111/jgs.17369 – ident: ref77 doi: 10.1007/s00520-019-05230-0 – ident: ref37 doi: 10.1080/07420528.2017.1293678 – ident: ref32 doi: 10.1016/j.ejon.2015.02.013 – ident: ref45 doi: 10.7748/phc.2017.e1225 – ident: ref94 doi: 10.1002/jso.26413 – ident: ref71 doi: 10.2196/17855 – ident: ref126 doi: 10.1007/s11764-022-01260-6 – ident: ref122 doi: 10.2196/29788 – ident: ref85 doi: 10.1016/j.clon.2021.04.008 – ident: ref99 doi: 10.1002/cam4.4382 – ident: ref67 doi: 10.1016/j.jgo.2019.01.010 – ident: ref97 doi: 10.2196/25791 – ident: ref62 doi: 10.14423/SMJ.0000000000000956 – ident: ref33 doi: 10.2196/mhealth.5426 – ident: ref53 doi: 10.1111/ijn.12658 – ident: ref115 doi: 10.1111/jgs.14589 – ident: ref69 doi: 10.1007/s00066-019-01548-0 – ident: ref66 doi: 10.1016/j.ejso.2019.04.013 – ident: ref114 doi: 10.1123/jmpb.2021-0046 – ident: ref18 doi: 10.1158/1078-0432.CCR-07-1147 – ident: ref91 doi: 10.2196/27975 – ident: ref124 doi: 10.2196/36284 – ident: ref8 doi: 10.1016/j.outlook.2019.04.005 – ident: ref21 doi: 10.3109/13685538.2011.582528 – ident: ref10 doi: 10.1200/JOP.2015.003715 – ident: ref127 doi: 10.4258/hir.2021.27.4.267 – ident: ref130 doi: 10.2307/249008 – ident: ref30 doi: 10.1097/NCC.0000000000000128 – ident: ref59 doi: 10.1038/s41430-019-0418-9 – ident: ref35 doi: 10.1016/j.pmedr.2016.06.022 – ident: ref34 doi: 10.1007/s10552-016-0787-5 – ident: ref48 doi: 10.1080/07420528.2017.1391278 – ident: ref103 doi: 10.3390/cancers14112742 – ident: ref26 doi: 10.1177/1534735414542484 – ident: ref89 doi: 10.1245/s10434-021-09707-3 – ident: ref36 doi: 10.1016/j.ijrobp.2017.02.002 – ident: ref123 doi: 10.2196/47380 – ident: ref68 doi: 10.1002/jso.25789 – ident: ref12 doi: 10.2196/29027 – ident: ref15 doi: 10.7326/M18-0850 – ident: ref118 doi: 10.3322/caac.21608 – ident: ref3 doi: 10.1016/S1470-2045(18)30348-6 – ident: ref100 doi: 10.1186/s12885-022-09629-7 – ident: ref52 doi: 10.1016/j.jgo.2017.09.008 – ident: ref80 doi: 10.1016/j.clml.2020.06.024 – ident: ref75 doi: 10.21037/jtd.2020.01.23 – ident: ref11 doi: 10.1136/bmjopen-2020-046393 – ident: ref16 doi: 10.2196/13320 – ident: ref29 doi: 10.1177/1049909113510963 – ident: ref41 doi: 10.1007/s12529-016-9575-6 – ident: ref74 doi: 10.1016/j.ejso.2020.06.012 – ident: ref47 doi: 10.1017/S1478951517000815 – ident: ref81 doi: 10.1001/jamasurg.2019.4702 – ident: ref121 doi: 10.1016/j.jpainsymman.2019.08.016 – ident: ref20 doi: 10.1007/s00520-009-0776-2 – ident: ref54 doi: 10.1186/s12966-018-0686-0 – ident: ref129 doi: 10.1097/CIN.0000000000001109 – ident: ref49 doi: 10.1016/j.lungcan.2018.03.010 – ident: ref58 doi: 10.1080/0284186X.2019.1633473 – ident: ref98 doi: 10.1016/j.urolonc.2020.11.035 – ident: ref44 doi: 10.1177/1049909116649948 – ident: ref56 doi: 10.1186/s12885-018-5189-5 – ident: ref61 doi: 10.1136/bmjopen-2018-025114 – ident: ref63 doi: 10.1097/JU.0000000000000050 – ident: ref84 doi: 10.1186/s41687-020-00255-0 – ident: ref86 doi: 10.1186/s12885-021-08084-0 – ident: ref57 doi: 10.1017/S1478951518001074 – ident: ref117 doi: 10.1139/H07-074 – start-page: 291 year: 2023 ident: ref120 publication-title: Clinical Research Informatics doi: 10.1007/978-3-031-27173-1_15 – ident: ref70 doi: 10.2196/19238 – ident: ref43 doi: 10.1007/s00520-017-3625-8 – ident: ref2 doi: 10.1007/s11764-016-0553-4 – ident: ref23 doi: 10.1007/s11764-013-0293-7 – ident: ref25 doi: 10.1016/j.eururo.2013.09.041 – ident: ref7 doi: 10.1093/jamia/ocv184 – ident: ref109 doi: 10.1016/S1470-2045(16)30573-3 |
SSID | ssj0020491 |
Score | 2.4311209 |
SecondaryResourceType | review_article |
Snippet | The advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated health data... Background The advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated... Background:The advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated... BackgroundThe advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | e57379 |
SubjectTerms | Aged Cancer Cardiovascular disease Care and treatment Chronic illnesses Citation management software Clinical outcomes Coaching Communications technology Data collection Diabetes Disease management Health aspects Health information Humans Information technology Medical equipment Medical personnel Medical records Medical research Medical Subject Headings-MeSH Motivation Multimedia Neoplasms Older people Outdoor air quality Patient compliance Patient Generated Health Data Patient participation Patient-centered care Patients Physical activity Physiology Quality of life Review Wearable computers |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NT9wwEB0hDqgSQi0tJS0gI1XtKWrWsR2nt5QPISRoD0VF6sGyHVvlkq1g-f-dib3bjXrgwjXOamPPTGZeZuYNwAfK-CM27kvZh7oU3MeyrXpeWnQdvWqssI6-d1xdq4sbcXkrb9dGfVFNWKIHTgf3WQkvfatohDw6u-i01SritaaRIdZ2ROvo85ZgKkMtjHtnW7BNhc6oYoj6a6rVWvM8I0H__6_hNT80rZFcczrnL2EnR4usS0_5CjbCsAuHudeAfWS5mYgOl2Ur3YWtq5wvfw2_un_5aTaP7HtiUS0T2TQGmyy1IbFTu7Cso8FD7BvN7WYd8XI8sJ93uHhCmnH_Bf9h7K5iKZ_wBm7Oz36cXJR5nELphW4XpUB_aB1HhBJUFbWPXttGzpzgVjY9b6S1VatjLVsuvfa69zLW2ta9iDE6z-s92BzmQ9gH1gQnKfSzUisRgnP4xteuEi5WVlk5K-BoedTmT2LNMIg2SBZmlEUBX0kAq0UiuR4voOhNFr15SvQFfCLxGTJFlJG3uaMAn5FIrUyH0AnhE4akBRxM7kQT8tPlpQKYbMIPhlJQxM7PmwKOV8v0SypLG8L8Ee_BaFbSNyPc0NukL6stYeRHWVtVgJ5o0mTP05Xh7vdI8I2gr1aynb17jlN6Dy84zSymSnNxAJuL-8dwiIHUwh2NNvMXUuYbmg priority: 102 providerName: Directory of Open Access Journals |
Title | Application of Patient-Generated Health Data Among Older Adults With Cancer: Scoping Review |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39903506 https://www.proquest.com/docview/3222368527 https://www.proquest.com/docview/3163501509 https://pubmed.ncbi.nlm.nih.gov/PMC11836591 https://doaj.org/article/64c5c968517743fb8a86f4c5775ef3a0 |
Volume | 27 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEB-0hSJI0ao1tT1WEH0KJpvdZOOLpLWlCNcWsXjgQ9jd7Gpfknp3_f-dSfY-guDLPWQSLpuZ2Z3P3wC8o4w_-sZNLBuXxYJbH5dJw2ONR0eTF1poQ_GO6VV-eSu-zuQsBNwWoaxytSf2G3XTWYqRf6SMAIGl8-Lz_Z-YpkZRdjWM0HgMuwRdRiVdxWzjcKH1m-7BUyp3RkFD3z-jiq2t86eH6f93M946jcaVkltHz8Uz2A82I6sGJj-HR649gJPQccDes9BSRJ-YBV09gL1pyJq_gJ_VJkvNOs9uBizVeICcRpOTDc1I7ItealbR-CF2TdO7WUXoHAv24w6JZyQf80_4D32PFRuyCi_h9uL8-9llHIYqxFaochkLPBW14einuDzxynqrdCFTI7iWRcMLqXVSKp_JkkurrGqs9JnSWSO898by7BXstF3rXgMrnJFkAGqpcuGcMbjvK5MI4xOda5lGMFl96vp-wM6o0ecgXtQ9LyI4JQasiQR13V_o5r_qoDl1Lqy0JXI-RUs180ZplXu8VhTS-UwnEXwg9tWkkMgjq0NfAb4jQVvVFTpQ6EShYRrB8ehOVCQ7Jq8EoA6KvKg3YhfB2zWZnqTitNZ1D3gP2rSSIke4oMNBXtZLQvuPcrd5BGokSaM1jynt3e8e5htdvyyXZXr0__d6A084zSSmSnJxDDvL-YM7QUNpaSa9Nkxg9_T86ubbpA834O80vf4L2dYXDg |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3ra9RAEB_KFaogovUVbesKPj6F5rGbbASR9MXV9s4iLS34Ie5udrVfknp3Rfyn_BudSXLXC4Lf-jWTkGxmduY3Oy-A1xTxR9-49EVpY59HxvlZUEa-QtNRJqniStN5x2icDM_4pwtxsQJ_5rUwlFY514mNoi5rQ2fk2xQRoGbpUfrx6qdPU6MoujofodGKxZH9_QtdtumHwz3k75soOtg_3R363VQB33CZzXyOZkHpCIG6TQInjTNSpSLUPFIiLaNUKBVk0sUii4SRRpZGuFiquOTOOW2o0QGq_FUeoyszgNWd_fHJl4WLh3g7XIN7lGCNor0t0phyxJYsXjMY4F_1v2T_-rmZS8bu4AHc71Aqy1uxeggrtlqHza7Ggb1lXRETMZV12mEd1kZdnP4RfM1v4uKsduyk7d7qt02uEeSytvyJ7amZYjkNPGKfaV44y6kfyJSdXyJxlyRy8h7f0FR1sTaO8RjObuWHP4FBVVf2GbDUakGQUwmZcGu1RksjdcC1C1SiROjB1vxXF1dtt44CvRziRdHwwoMdYsCCSM21mwv15HvR7dUi4UaYDGUtRGwcOy2VTBxeS1NhXawCD94R-wpSAcgjo7pKBvxGaqZV5OiyoduGUNiDjd6duHVNnzwXgKJTHdPiRtA9eLUg05OUDlfZ-hrvQRQt6KwKF_S0lZfFkhBxUrQ48UD2JKm35j6luvzRNBZHZzNORBY-__93vYQ7w9PRcXF8OD56AXcjmohMeex8AwazybXdRJg201vd3mDw7ba3419RY1Om |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9RAFD6UCosgovWW2tYRvDyF5jKTTASR2HVpra19sLjgQ5yZzGhfknZ3i_jX_HWek8vuBsG3vmYSksm5fWfODeAFRfzRNy59UdrY55FxfhaUka_QdJRJqrjSdN5xcpocnvOPUzHdgD99LQylVfY6sVHUZW3ojHyfIgLULB1dddelRZyNJ-8ur3yaIEWR1n6cRssix_b3L3Tf5m-Pxkjrl1E0-fDl4NDvJgz4hsts4XM0EUpHCNptEjhpnJEqFaHmkRJpGaVCqSCTLhZZJIw0sjTCxVLFJXfOaUNND1D930pjEZKMpdOVs4fIOxzBHUq1RibfF2lM2WJrtq8ZEfCvIVizhMMszTWzN7kHdzu8yvKWwe7Dhq22YLerdmCvWFfORORlnZ7YgtFJF7F_AN_yVYSc1Y6dtX1c_bbdNcJd1hZCsbFaKJbT6CP2mSaHs5w6g8zZ1wtcPCDenL3BNzT1XayNaDyE8xv53Y9gs6or-wRYarUg8KmETLi1WqPNkTrg2gUqUSL0YK__1cVl27ejQH-HaFE0tPDgPRFguUhttpsL9exH0UltkXAjTIZcFyJKjp2WSiYOr6WpsC5WgQeviXwFKQOkkVFdTQN-I7XVKnJ03tCBQ1Dswc7gThRiM1zuGaDolMi8WLG8B8-Xy_QkJcZVtr7GexBPCzq1wg09bvlluSXEnhQ3TjyQA04a7Hm4Ul38bFqMo9sZJyILt___Xc9ghEJYfDo6PX4KtyMajUwJ7XwHNheza7uLeG2h9xrBYPD9piXxLyqDVnY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Application+of+Patient-Generated+Health+Data+Among+Older+Adults+With+Cancer%3A+Scoping+Review&rft.jtitle=Journal+of+medical+Internet+research&rft.au=Kim%2C+Yesol&rft.au=Kim%2C+Geonah&rft.au=Cho%2C+Hyeonmi&rft.au=Kim%2C+Yeonju&rft.date=2025-02-04&rft.pub=Journal+of+Medical+Internet+Research&rft.issn=1439-4456&rft.volume=27&rft.issue=5&rft_id=info:doi/10.2196%2F57379&rft.externalDocID=A826182405 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1438-8871&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1438-8871&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1438-8871&client=summon |